Skip to content
Disclosery

EXANE DERIVATIVES: SPGI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on SPGI, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,055 SPGI shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,055 shares
    Change vs previous 13F -26 shares

    0.4% of the 13F portfolio, value $692,517.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,081 shares
    Change vs previous 13F -481 shares

    0.24% of the 13F portfolio, value $853,532.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,562 shares
    Change vs previous 13F -1,441 shares

    0.29% of the 13F portfolio, value $1,209,041.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 4,003 shares
    Change vs previous 13F -266 shares

    0.42% of the 13F portfolio, value $1,700,774.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,269 shares
    Change vs previous 13F +286 shares

    0.41% of the 13F portfolio, value $1,745,768.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 3,983 shares
    Change vs previous 13F +182 shares

    0.42% of the 13F portfolio, value $1,405,419.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 3,801 shares
    Change vs previous 13F +32 shares

    0.38% of the 13F portfolio, value $1,249,445.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 3,769 shares
    Change vs previous 13F not available

    0.44% of the 13F portfolio, value $1,359,026.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).